Paolo Tarantino/X
May 14, 2025, 09:24
Paolo Tarantino: Celebrating the Publication of New Review Article on HER2 Testing in the Era of Novel ADC
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post by Jame Abraham, Chairman and Professor at the Department of Hematology and Medical Oncology at Cleveland Clinic, on X, adding:
“Perfectly timed with ESMO Breast 2025, we celebrate the publication of our latest review article on how to test for HER2 expression in the ADC era — just published in JCO Oncology Practice.”
Quoting Jame Abraham‘s post:
“Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates | JCO Oncology Practice
Excellent article by Paolo Tarantino and colleagues to help us to undestand Her-2 testing now!”
Title: Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates
Journal: JCO Oncology Practice
Authors: Eleonora Nicolò, Caterina Gianni, and Paolo Tarantino,
More posts featuring Breast Cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 14, 2025, 09:14
May 14, 2025, 08:56
May 14, 2025, 08:22